National Research EBITDA Margin 2010-2023 | NRC
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for National Research (NRC) over the last 10 years. The current EBITDA margin for National Research as of December 31, 2023 is .
| National Research EBITDA Margin Historical Data |
| Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
| 2023-12-31 |
$0.15B |
$0.05B |
31.08% |
| 2023-09-30 |
$0.15B |
$0.05B |
31.76% |
| 2023-06-30 |
$0.15B |
$0.05B |
31.76% |
| 2023-03-31 |
$0.15B |
$0.05B |
32.89% |
| 2022-12-31 |
$0.15B |
$0.05B |
34.44% |
| 2022-09-30 |
$0.15B |
$0.05B |
34.44% |
| 2022-06-30 |
$0.15B |
$0.06B |
36.42% |
| 2022-03-31 |
$0.15B |
$0.06B |
37.33% |
| 2021-12-31 |
$0.15B |
$0.06B |
38.78% |
| 2021-09-30 |
$0.14B |
$0.06B |
38.89% |
| 2021-06-30 |
$0.14B |
$0.06B |
39.29% |
| 2021-03-31 |
$0.14B |
$0.05B |
38.52% |
| 2020-12-31 |
$0.13B |
$0.05B |
38.06% |
| 2020-09-30 |
$0.13B |
$0.05B |
38.64% |
| 2020-06-30 |
$0.13B |
$0.05B |
37.69% |
| 2020-03-31 |
$0.13B |
$0.05B |
38.46% |
| 2019-12-31 |
$0.13B |
$0.05B |
38.58% |
| 2019-09-30 |
$0.13B |
$0.05B |
37.60% |
| 2019-06-30 |
$0.12B |
$0.05B |
37.40% |
| 2019-03-31 |
$0.12B |
$0.04B |
35.83% |
| 2018-12-31 |
$0.12B |
$0.04B |
34.17% |
| 2018-09-30 |
$0.12B |
$0.04B |
33.61% |
| 2018-06-30 |
$0.12B |
$0.04B |
31.36% |
| 2018-03-31 |
$0.12B |
$0.04B |
32.20% |
| 2017-12-31 |
$0.12B |
$0.04B |
33.33% |
| 2017-09-30 |
$0.12B |
$0.04B |
33.91% |
| 2017-06-30 |
$0.11B |
$0.04B |
34.51% |
| 2017-03-31 |
$0.11B |
$0.04B |
33.33% |
| 2016-12-31 |
$0.11B |
$0.04B |
32.11% |
| 2016-09-30 |
$0.11B |
$0.03B |
31.78% |
| 2016-06-30 |
$0.11B |
$0.03B |
32.38% |
| 2016-03-31 |
$0.10B |
$0.03B |
32.04% |
| 2015-12-31 |
$0.10B |
$0.03B |
30.69% |
| 2015-09-30 |
$0.10B |
$0.03B |
29.00% |
| 2015-06-30 |
$0.10B |
$0.03B |
29.29% |
| 2015-03-31 |
$0.10B |
$0.03B |
29.29% |
| 2014-12-31 |
$0.10B |
$0.03B |
31.31% |
| 2014-09-30 |
$0.10B |
$0.03B |
31.96% |
| 2014-06-30 |
$0.10B |
$0.03B |
31.58% |
| 2014-03-31 |
$0.09B |
$0.03B |
31.18% |
| 2013-12-31 |
$0.09B |
$0.03B |
30.43% |
| 2013-09-30 |
$0.09B |
$0.03B |
30.77% |
| 2013-06-30 |
$0.09B |
$0.03B |
31.11% |
| 2013-03-31 |
$0.09B |
$0.03B |
31.46% |
| 2012-12-31 |
$0.09B |
$0.03B |
31.40% |
| 2012-09-30 |
$0.08B |
$0.03B |
31.33% |
| 2012-06-30 |
$0.08B |
$0.03B |
30.86% |
| 2012-03-31 |
$0.08B |
$0.02B |
30.77% |
| 2011-12-31 |
$0.08B |
$0.02B |
31.58% |
| 2011-09-30 |
$0.07B |
$0.02B |
30.14% |
| 2011-06-30 |
$0.07B |
$0.02B |
30.00% |
| 2011-03-31 |
$0.07B |
$0.02B |
30.30% |
| 2010-12-31 |
$0.06B |
$0.02B |
30.16% |
| 2010-09-30 |
$0.06B |
$0.02B |
31.15% |
| 2010-06-30 |
$0.06B |
$0.02B |
30.51% |
| 2010-03-31 |
$0.06B |
$0.02B |
30.51% |
| 2009-12-31 |
$0.06B |
$0.02B |
28.81% |
| Sector |
Industry |
Market Cap |
Revenue |
| Business Services |
Business Information Services |
$0.801B |
$0.149B |
|
National Research Corporation offers analytics and insights that facilitate revenue growth, patient, employee, customer retention and patient engagement for healthcare providers, payers and other healthcare organizations. Its services include capture, interpretation, transmittal and benchmarking of critical data elements from various healthcare consumers. National Research Corporation is headquartered in Lincoln, Nebraska.
|
